Monograph Capital Advisors, L.P.Firm match from fund name (lower confidence)
Monograph Capital Partners II, L.P.
Open: first sale Mar 2024, per Form D (fund age approximates vintage)
- Vintage
- 2024
- Fund size
- $153.69M (Form D)
- Stages
- Not stated
- Sectors
- Biotech, Digital health
- Regions
- Global
01 · Thesis
Monograph Capital finds and funds innovative life sciences companies, aiming to translate promising science into potential life-changing treatments for patients. The team focuses on sourcing scientific innovation and supporting strong companies, combining sourcing, pharma relationships and medical expertise.Inferred from the firm's website
02 · Initial check
$1.54M to $2.56M (estimated from fund size)
Estimated from Form D
03 · Who to approach
Named on this fund's Form D
- Fred Cohen, Partner and Chairman, MD, DPhil
- Charles Conn, Partner, MBA, MA
04 · Deals
No deals attributed to this fund yet.
05 · Evidence
Firm-wideMonograph Capital invests in innovative life sciences companies, aiming to translate promising science into life-changing treatments for patients.
We find and fund innovative life sciences companies, aiming to help translate promising science into potential, life-changing treatments for patients around the world.
https://www.monograph.bio/
06 · Sources
Last verified: Oct 28, 2026